A case of spurious hypercalcitoninemia: A cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia

[1]  A. Grauer,et al.  Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  F. Raue,et al.  Routine calcitonin determination in thyroid nodules – an effective approach? , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[3]  M. Genel,et al.  Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children. , 1999, The Journal of pediatrics.

[4]  B. Caillou,et al.  Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial disease. , 1999, Human pathology.

[5]  O. Schneegans,et al.  Hypercalcitoninemia, nodular goiter, and pancreatic tumor. , 1999, Thyroid : official journal of the American Thyroid Association.

[6]  J. Doppman,et al.  Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  G. Sterrett,et al.  Medullary carcinoma of the thyroid , 1998, Cancer.

[8]  J. Moley,et al.  Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia. , 1998, Surgical oncology clinics of North America.

[9]  E. Baudin,et al.  Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours. , 1998, British Journal of Cancer.

[10]  J. White,et al.  Serum calcitonin precursors in sepsis and systemic inflammation. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  M. A. Lima,et al.  Quantitative analysis of C cells in Hashimoto's thyroiditis. , 1998, Thyroid : official journal of the American Thyroid Association.

[12]  C. Bieglmayer,et al.  Routine measurement of plasma calcitonin in nodular thyroid diseases. , 1997, The Journal of clinical endocrinology and metabolism.

[13]  R. Gagel,et al.  The goitrous patient with an elevated serum calcitonin--what to do? , 1997, The Journal of clinical endocrinology and metabolism.

[14]  P. Caron,et al.  Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. , 1997, The Journal of clinical endocrinology and metabolism.

[15]  K. Becker,et al.  Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[16]  C Eng,et al.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.

[17]  S. Allen,et al.  Hypercalcitoninemia and inappropriate calciuria in the acute trauma patient. , 1996, Journal of critical care.

[18]  K. Becker,et al.  Pneumonitis-associated hyperprocalcitoninemia. , 1996, The American journal of the medical sciences.

[19]  J. Reinsberg.  Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. , 1996, Clinical biochemistry.

[20]  K. Molberg,et al.  Physiologic versus neoplastic C‐cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities , 1996, Cancer.

[21]  H. Gharib,et al.  Controversies in the management of cold, hot, and occult thyroid nodules. , 1995, The American journal of medicine.

[22]  J. Lenders,et al.  Plasma Metanephrines in the Diagnosis of Pheochromocytoma , 1995, Annals of Internal Medicine.

[23]  M. Rieu,et al.  Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules , 1995, Clinical endocrinology.

[24]  M. Sheppard.  Should serum calcitonin be measured routinely in all patients with nodular thyroid disease? , 1995, Clinical endocrinology.

[25]  B. Franc,et al.  C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. , 1994, Human pathology.

[26]  A. Pinchera,et al.  Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[27]  R. Kelch,et al.  Thyroid masses: approach to diagnosis and management in childhood and adolescence. , 1993, Pediatrics in review.

[28]  J. Farndon,et al.  Medullary thyroid carcinoma , 1993, The British journal of surgery.

[29]  M. S. Lewis,et al.  Serum calcitonin may be a marker for inhalation injury in burns. , 1992, The Journal of burn care & rehabilitation.

[30]  D. Gaskin,et al.  Hashimoto's thyroiditis with medullary carcinoma. , 1992, Canadian journal of surgery. Journal canadien de chirurgie.

[31]  M. Brennan,et al.  Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. , 1991, The American journal of surgical pathology.

[32]  C. Beglinger,et al.  Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients , 1991, Regulatory Peptides.

[33]  H. Wisser,et al.  Antibodies as a source of analytical errors. , 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[34]  O. Gedik,et al.  THE EFFECT OF RADIOACTIVE IODINE TREATMENT ON THYROID C CELLS , 1990, Clinical endocrinology.

[35]  H. Trachtman,et al.  Hypocalcemia and hypercalcitoninemia in critically ill children. , 1990, Critical care medicine.

[36]  E. Mallet.  Hypercalcitoninemia in acutely ill children. , 1990, The Journal of pediatrics.

[37]  R. W. Pryor,et al.  Hypercalcitoninemia and hypocalcemia in acutely ill children: studies in serum calcium, blood ionized calcium, and calcium-regulating hormones. , 1989, The Journal of pediatrics.

[38]  L. Thim,et al.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma. , 1988, The Biochemical journal.

[39]  Baskin Hj,et al.  Influence of needle biopsy on management of thyroid nodules: reasons to expand its use. , 1987 .

[40]  M. Saad,et al.  Medullary Carcinoma of the Thyroid: A STUDY OF THE CLINICAL FEATURES AND PROGNOSTIC FACTORS IN 161 PATIENTS , 1984, Medicine.

[41]  J. Body,et al.  "Nonspecific" increases in plasma immunoreactive calcitonin in healthy individuals: discrimination from medullary thyroid carcinoma by a new extraction technique. , 1984, Clinical chemistry.

[42]  M. Girelli,et al.  Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow‐up of medullary thyroid carcinoma , 1984, Cancer.

[43]  J. Body,et al.  Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. , 1983, The Journal of clinical endocrinology and metabolism.

[44]  K. Becker,et al.  Radioimmunoassay of calcitonin in normal human urine. , 1978, Analytical chemistry.

[45]  K. Gautvik,et al.  MEDULLARY CARCINOMA OF THE THYROID IN NORWAY , 1976 .

[46]  B. Maes,et al.  Multiple Endocrine Neoplasia Type 2: Management of Patients and Subjects at Risk , 1997 .

[47]  P. Niccoli,et al.  [Hypercalcitoninemia in conditions other than medullary cancers of the thyroid]. , 1996, Annales d'endocrinologie.

[48]  S. Guyétant,et al.  [Non-neoplastic hypercalcitoninemia. Pathological anatomy]. , 1996, Annales d'endocrinologie.

[49]  E. Baudin,et al.  Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. , 1995, European journal of endocrinology.

[50]  M. Eliasson,et al.  Influence of smoking and snuff use on electrolytes, adrenal and calcium regulating hormones. , 1993, Acta endocrinologica.

[51]  W. Hecker,et al.  Surgery for benign and malignant diseases of the thyroid gland in childhood. , 1991, Progress in pediatric surgery.

[52]  J. Tucci,et al.  C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. , 1989, The American journal of surgical pathology.

[53]  E. Barabás,et al.  Parathormone and calcitonin secretion in endemic goiter. , 1989, Endocrinologie.

[54]  A. Silverberg,et al.  Immunocytochemistry of the thyroid in surgical and cytologic specimens. , 1988, Archives of pathology & laboratory medicine.

[55]  C. Calmettes.  On the presence of autoantibodies in the plasma of patients suffering from medullary carcinoma of the thyroid. , 1985, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[56]  Dambacher Ma,et al.  Differential diagnosis of hypercalcitoninemia. , 1984 .